A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
M.D. Anderson Cancer Center
University of Nebraska
Novartis
Medicenna Therapeutics, Inc.
Turnstone Biologics, Corp.
Checkpoint Therapeutics, Inc.
Taproot Health
Stanford University